GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Price-to-Free-Cash-Flow

Aptorum Group (Aptorum Group) Price-to-Free-Cash-Flow : N/A (As of Apr. 29, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Price-to-Free-Cash-Flow?

As of today (2024-04-29), Aptorum Group's share price is $5.28. Aptorum Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.13. Hence, Aptorum Group's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Aptorum Group's Price-to-Free-Cash-Flow or its related term are showing as below:

APM's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.52
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Aptorum Group's Free Cash Flow per Share for the six months ended in Jun. 2023 was $-1.61. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-3.13.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 11.10% per year.

During the past 6 years, Aptorum Group's highest 3-Year average Free Cash Flow per Share Growth Rate was 11.10% per year. The lowest was 9.90% per year. And the median was 10.50% per year.


Aptorum Group Price-to-Free-Cash-Flow Historical Data

The historical data trend for Aptorum Group's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Price-to-Free-Cash-Flow Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aptorum Group's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Aptorum Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptorum Group's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aptorum Group's Price-to-Free-Cash-Flow falls into.



Aptorum Group Price-to-Free-Cash-Flow Calculation

Aptorum Group's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=5.28/-3.133
=N/A

Aptorum Group's Share Price of today is $5.28.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptorum Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.13.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Aptorum Group  (NAS:APM) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Aptorum Group Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptorum Group (Aptorum Group) Business Description

Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group (Aptorum Group) Headlines

From GuruFocus

Aptorum Group Announces Offering of $3 Million Convertible Note due 2023

By Business Wire Business Wire 12-09-2022